JPK Instruments Sponsors the German Museum of Masterpieces of Technology and Science in Munich
News Nov 27, 2009
JPK Instruments has joined the sponsors of the German Museum of Masterpieces of Technology and Science in Munich by donating a NanoWizard® atomic force microscope worth 150,000 euros. Dedicated to nano research, the Glass Laboratory at the Museum allows all visitors to watch researchers at work.
Frank Pelzer, CEO of JPK: “Back in the fifties, mankind took on big challenges such as space exploration and the moon landing. Without the achievements of those bold pioneers we would today have to do without satellites and numerous other revolutionary applications such as mobile phones, GPS services and satnav systems.
Today we are challenged not to look towards the far horizons but, on the contrary, to explore the smallest and most minute details of matter. As we go down to the nano, atomic and molecular levels, we work towards the revolutions of the future - primarily in the medical and life sciences areas.”
The state of the art in nano research is showcased in the Glass Laboratory at the Museum. Says Frank Pelzer: “We believe that it is very important to give the interested public an opportunity to see nano research in action. This is why we have taken the opportunity of our 10th company anniversary to support the Glass Laboratory through the donation of one of our NanoWizard® series atomic force microscopes.”
JPK Instruments’ development of these atomic force microscopes over the past years has resulted in a globally unique base technology which is sold to German and international research facilities. Atomic force microscopes are the eyes and fingers of the nanoworld and as such highlight the successful development of German high-tech products. Despite intensive research spending JPK has consistently generated profits in recent years.
Frank Pelzer says: “When we launched our business 10 years ago, we also benefited from public start-up subsidies which have contributed to our success. This has been a factor in our decision to now support a public project such as the German Museum of Masterpieces of Technology and Science.”
Combating Cancer by Targeting Sugar ReceptorsNews
Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Prof. Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018